SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem India informs about outcome of board meeting

22 Jun 2026 Evaluate
Pursuant to Regulation 30 read with Schedule Il of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and applicable SEBI Circulars, Syschem India has informed that the Board of Directors of the Company at its meeting held on 22nd June 2026, has approved the allotment of 2,50,000 (Two Lakhs Fifty Thousand only) Equity Shares of face value of Rs 10 each pursuant to the exercise of vested stock options by eligible employees under the Company's ESOP Scheme. The details of 'employees’ to whom equity shares have been allotted are enclosed.

The above information is a part of company’s filings submitted to BSE.

Syschem (India) Share Price

42.11 -0.35 (-0.82%)
15-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1952.45
Dr. Reddys Labs. 1229.80
Cipla 1437.95
Lupin 2491.80
Zydus Lifesciences 1154.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: